ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Transfusion Medicine

Transfusion Medicine

Volume 12 Issue 2, Pages 85 - 106

Published Online: 29 Apr 2002

Journal compilation © 2010 British Blood Transfusion Society



Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 229K)  | Related Articles | Citation Tracking

REVIEW ARTICLE
Tick-borne diseases in transfusion medicine
L. Pantanowitz , S. R. Telford III and M. E. Cannon
 Department of Pathology (LP, MEC), Beth Israel Deaconess Medical Center, Harvard Medical School and Harvard School of Public Health (SRT), Boston, MA, USA
Correspondence: Dr L. Pantanowitz, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. E-mail: lpantanowitz@hotmail.com
Copyright Blackwell Science Ltd, 2002
KEYWORDS
babesia • blood donor • rickettsia • spirochaete • tick • transfusion

ABSTRACT

SummaryTicks are effective vectors of viral, bacterial, rickettsial and parasitic diseases. Many of the tick-borne diseases (TBDs) are of significance to transfusion medicine, either because of the risks they pose to the blood supply or the necessity for blood products required in their treatment. The transmission of tick-borne pathogens via blood transfusion is of global concern. However, among transfusion medicine practitioners, experience with most of these microorganisms is limited. Transfusion transmission of TBDs has been documented largely by means of single case reports. A better understanding of the epidemiology, biology and management of this group of diseases is necessary in order to assess the risks they pose to the blood supply and to help guide effective prevention strategies to reduce this risk. Unique methods are required to focus on donor selection, predonation questioning, mass screening and inactivation or eradication procedures. The role of the transfusion medicine service in their treatment also needs to be better defined. This article reviews the growing body of literature pertaining to this emerging field of transfusion medicine and offers some recommendations for transfusionists in dealing with TBDs.


Received 6 June 2001; accepted for publication 29 January 2002

DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1365-3148.2002.00358.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member